| Year |
Citation |
Score |
| 2023 |
Banerjee D, Bobolla S, Okochi S, Angelastro JM, Kadenhe-Chiweshe AV, Lopez G, Califano A, Connolly EP, Greene LA, Yamashiro D. Activating Transcription Factor 5 (ATF5) Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance. Cancer Research Communications. PMID 38014922 DOI: 10.1158/2767-9764.CRC-23-0154 |
0.352 |
|
| 2020 |
Hua ZY, Hansen JN, He M, Dai SK, Choi Y, Fulton MD, Lloyd SM, Szemes M, Sen J, Ding HF, Angelastro JM, Fei X, Li HP, Wu CR, Yang SY, et al. PRMT1 promotes neuroblastoma cell survival through ATF5. Oncogenesis. 9: 50. PMID 32415090 DOI: 10.1038/s41389-020-0237-9 |
0.328 |
|
| 2019 |
Sun X, Jefferson P, Zhou Q, Angelastro JM, Greene LA. Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD. Molecular Cancer Research : McR. PMID 31676720 DOI: 10.1158/1541-7786.Mcr-19-0631 |
0.451 |
|
| 2019 |
Allen SA, Datta S, Sandoval J, Tomilov A, Sears T, Woolard K, Angelastro JM, Cortopassi GA. Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer. Mitochondrion. PMID 31654752 DOI: 10.1016/J.Mito.2019.09.009 |
0.31 |
|
| 2019 |
Sun X, Angelastro JM, Merino D, Zhou Q, Siegelin MD, Greene LA. Dominant-negative ATF5 rapidly depletes survivin in tumor cells. Cell Death & Disease. 10: 709. PMID 31551409 DOI: 10.1038/S41419-019-1872-Y |
0.447 |
|
| 2019 |
Sears TK, Datta S, Cortopassi G, Angelastro J, Woolard K. Abstract 3846: Targeting epigenetic dysregulation in isocitrate dehydrogenase mutant glioblastoma Cancer Research. 79: 3846-3846. DOI: 10.1158/1538-7445.Am2019-3846 |
0.347 |
|
| 2017 |
Sears TK, Angelastro JM. The transcription factor ATF5: role in cellular differentiation, stress responses, and cancer. Oncotarget. 8: 84595-84609. PMID 29137451 DOI: 10.18632/Oncotarget.21102 |
0.364 |
|
| 2017 |
Angelastro JM. Targeting ATF5 in Cancer. Trends in Cancer. 3: 471-474. PMID 28718401 DOI: 10.1016/J.Trecan.2017.05.004 |
0.348 |
|
| 2017 |
Wald JH, Hatakeyama J, Printsev I, Cuevas A, Fry WHD, Saldana MJ, VanderVorst K, Rowson-Hodel A, Angelastro JM, Sweeney C, Carraway KL. Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination. Oncogene. 36: 5158-5167. PMID 28481871 DOI: 10.1038/Onc.2017.126 |
0.381 |
|
| 2017 |
York D, Sproul CD, Chikere N, Dickinson PJ, Angelastro JM. Expression and targeting of transcription factor ATF5 in dog gliomas. Veterinary and Comparative Oncology. PMID 28480569 DOI: 10.1111/Vco.12317 |
0.379 |
|
| 2016 |
Karpel-Massler G, Horst BA, Shu C, Chau L, Tsujiuchi T, Bruce JN, Canoll P, Greene LA, Angelastro JM, Siegelin MD. A synthetic cell-penetrating dominant-negative ATF5 peptide exerts anti-cancer activity against a broad spectrum of treatment resistant cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27126996 DOI: 10.1158/1078-0432.Ccr-15-2827 |
0.375 |
|
| 2016 |
Cates CC, Arias AD, Nakayama Wong LS, Lamé MW, Sidorov M, Cayanan G, Rowland DJ, Fung J, Karpel-Massler G, Siegelin MD, Greene LA, Angelastro JM. Regression/Eradication of gliomas in mice by a systemically-deliverable ATF5 dominant-negative peptide. Oncotarget. PMID 26863637 DOI: 10.18632/Oncotarget.7212 |
0.714 |
|
| 2015 |
Karpel-Massler G, Shu C, Chau L, Angelastro JM, Greene LA, Siegelin MD. Abstract 2923: A novel cell-penetrating peptide targeting ATF5 (CP-d/n-ATF5) exerts anti-cancer activity in vitro and in vivo against a broad spectrum of human cancers Cancer Research. 75: 2923-2923. DOI: 10.1158/1538-7445.Am2015-2923 |
0.379 |
|
| 2012 |
Lee HY, Angelastro JM, Kenney AM, Mason CA, Greene LA. Reciprocal actions of ATF5 and Shh in proliferation of cerebellar granule neuron progenitor cells. Developmental Neurobiology. 72: 789-804. PMID 22095825 DOI: 10.1002/Dneu.20979 |
0.42 |
|
| 2012 |
Arias A, Lamé MW, Santarelli L, Hen R, Greene LA, Angelastro JM. Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas. Oncogene. 31: 739-51. PMID 21725368 DOI: 10.1038/Onc.2011.276 |
0.709 |
|
| 2011 |
Cunningham CL, Martínez Cerdeño V, Navarro Porras E, Prakash AN, Angelastro JM, Willemsen R, Hagerman PJ, Pessah IN, Berman RF, Noctor SC. Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical development. Human Molecular Genetics. 20: 64-79. PMID 20935171 DOI: 10.1093/Hmg/Ddq432 |
0.32 |
|
| 2010 |
Angelastro JM, Lamé MW. Overexpression of CD133 promotes drug resistance in C6 glioma cells. Molecular Cancer Research : McR. 8: 1105-15. PMID 20663862 DOI: 10.1158/1541-7786.Mcr-09-0383 |
0.365 |
|
| 2009 |
Li G, Li W, Angelastro JM, Greene LA, Liu DX. Identification of a novel DNA binding site and a transcriptional target for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer cells. Molecular Cancer Research : McR. 7: 933-43. PMID 19531563 DOI: 10.1158/1541-7786.Mcr-08-0365 |
0.383 |
|
| 2009 |
Greene LA, Lee HY, Angelastro JM. The transcription factor ATF5: role in neurodevelopment and neural tumors. Journal of Neurochemistry. 108: 11-22. PMID 19046351 DOI: 10.1111/J.1471-4159.2008.05749.X |
0.45 |
|
| 2008 |
Lee HY, Angelastro JM, Kenney AM, Mason C, Greene L. Regulation of ATF5 during cerebellar granule neuron progenitor proliferation and differentiation International Journal of Developmental Neuroscience. 26: 847. DOI: 10.1016/J.Ijdevneu.2008.09.066 |
0.32 |
|
| 2007 |
Schrot RJ, Ma JH, Greco CM, Arias AD, Angelastro JM. Organotypic distribution of stem cell markers in formalin-fixed brain harboring glioblastoma multiforme. Journal of Neuro-Oncology. 85: 149-57. PMID 17516028 DOI: 10.1007/S11060-007-9401-8 |
0.696 |
|
| 2007 |
Monaco SE, Angelastro JM, Szabolcs M, Greene LA. The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines. International Journal of Cancer. Journal International Du Cancer. 120: 1883-90. PMID 17266024 DOI: 10.1002/Ijc.22469 |
0.357 |
|
| 2006 |
Angelastro JM, Canoll PD, Kuo J, Weicker M, Costa A, Bruce JN, Greene LA. Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5. Oncogene. 25: 907-16. PMID 16170340 DOI: 10.1038/Sj.Onc.1209116 |
0.452 |
|
| 2005 |
Greene LA, Angelastro JM. You can't go home again: transcriptionally driven alteration of cell signaling by NGF. Neurochemical Research. 30: 1347-52. PMID 16341597 DOI: 10.1007/S11064-005-8807-Y |
0.337 |
|
| 2005 |
Mason JL, Angelastro JM, Ignatova TN, Kukekov VG, Lin G, Greene LA, Goldman JE. ATF5 regulates the proliferation and differentiation of oligodendrocytes. Molecular and Cellular Neurosciences. 29: 372-80. PMID 15950153 DOI: 10.1016/J.Mcn.2005.03.004 |
0.392 |
|
| 2005 |
Angelastro JM, Mason JL, Ignatova TN, Kukekov VG, Stengren GB, Goldman JE, Greene LA. Downregulation of activating transcription factor 5 is required for differentiation of neural progenitor cells into astrocytes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 3889-99. PMID 15829641 DOI: 10.1523/Jneurosci.3447-04.2005 |
0.424 |
|
| 2004 |
Jabado O, Wang Q, Rideout HJ, Yeasmin M, Guo KX, Vekrellis K, Papantonis S, Angelastro JM, Troy CM, Stefanis L. RAIDD aggregation facilitates apoptotic death of PC12 cells and sympathetic neurons. Cell Death and Differentiation. 11: 618-30. PMID 14765136 DOI: 10.1038/Sj.Cdd.4401397 |
0.325 |
|
| 2003 |
Angelastro JM, Ignatova TN, Kukekov VG, Steindler DA, Stengren GB, Mendelsohn C, Greene LA. Regulated expression of ATF5 is required for the progression of neural progenitor cells to neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 4590-600. PMID 12805299 DOI: 10.1523/Jneurosci.23-11-04590.2003 |
0.431 |
|
| 2002 |
Ryu EJ, Harding HP, Angelastro JM, Vitolo OV, Ron D, Greene LA. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 10690-8. PMID 12486162 DOI: 10.1523/Jneurosci.22-24-10690.2002 |
0.301 |
|
| 2002 |
Töröcsik B, Angelastro JM, Greene LA. The basic region and leucine zipper transcription factor MafK is a new nerve growth factor-responsive immediate early gene that regulates neurite outgrowth. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 8971-80. PMID 12388604 DOI: 10.1523/Jneurosci.22-20-08971.2002 |
0.35 |
|
| 2002 |
Angelastro JM, Töröcsik B, Greene LA. Nerve growth factor selectively regulates expression of transcripts encoding ribosomal proteins. Bmc Neuroscience. 3: 3. PMID 11922865 DOI: 10.1186/1471-2202-3-3 |
0.351 |
|
| 2001 |
Angelastro JM, Moon NY, Liu DX, Yang AS, Greene LA, Franke TF. Characterization of a novel isoform of caspase-9 that inhibits apoptosis. The Journal of Biological Chemistry. 276: 12190-200. PMID 11278518 DOI: 10.1074/Jbc.M009523200 |
0.374 |
|
| 2000 |
Angelastro JM, Klimaschewski L, Tang S, Vitolo OV, Weissman TA, Donlin LT, Shelanski ML, Greene LA. Identification of diverse nerve growth factor-regulated genes by serial analysis of gene expression (SAGE) profiling. Proceedings of the National Academy of Sciences of the United States of America. 97: 10424-9. PMID 10984536 DOI: 10.1073/Pnas.97.19.10424 |
0.322 |
|
| 2000 |
Angelastro JM, Klimaschewski LP, Vitolo OV. Improved NlaIII digestion of PAGE-purified 102 bp ditags by addition of a single purification step in both the SAGE and microSAGE protocols Nucleic Acids Research. 28. PMID 10871385 DOI: 10.1093/Nar/28.12.E62 |
0.316 |
|
| 1998 |
Angelastro JM, Ho CL, Frappier T, Liem RK, Greene LA. Peripherin is tyrosine-phosphorylated at its carboxyl-terminal tyrosine. Journal of Neurochemistry. 70: 540-9. PMID 9453548 DOI: 10.1046/J.1471-4159.1998.70020540.X |
0.33 |
|
| 1994 |
Angelastro JM, Purich DL. Phosphorylation States of Actin Filament Adenine Nucleotides in Detergent-Extracted Neuronal Cytoskeletal Fractions Biochemical and Biophysical Research Communications. 201: 1490-1494. PMID 8024594 DOI: 10.1006/Bbrc.1994.1872 |
0.546 |
|
| 1994 |
Purich DL, Angelastro JM. Microtubule dynamics: Bioenergetics and control Adv.Enzymol.Relat.Areas Mol.Biol.. 69: 121-154. PMID 7817867 DOI: 10.1002/9780470123157.Ch4 |
0.496 |
|
| 1992 |
Angelastro JM, Purich DL. Adenine and guanine nucleotide content of triton-extracted cytoskeletal fractions of nonmuscle cells Analytical Biochemistry. 204: 47-52. PMID 1514695 DOI: 10.1016/0003-2697(92)90137-V |
0.575 |
|
| 1991 |
Eaker EY, Angelastro JM, Purich DL, Sninsky CA. Evidence against impaired brain microtubule protein polymerization at high glucose concentrations or during diabetes mellitus Journal of Neurochemistry. 56: 2087-2093. PMID 2027016 DOI: 10.1111/J.1471-4159.1991.Tb03470.X |
0.53 |
|
| 1990 |
Angelastro JM, Purich DL. Apparently irreversible GTP hydrolysis attends tubulin self-assembly European Journal of Biochemistry. 191: 507-511. PMID 2384097 DOI: 10.1111/J.1432-1033.1990.Tb19150.X |
0.528 |
|
| Show low-probability matches. |